Compare IDEXX Laboratories, Inc. (IDXX) vs Motorola Solutions Inc (MSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Motorola Solutions Inc — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Motorola Solutions Inc trades at $443.51 (market cap $74.00B). The key difference: Motorola Solutions Inc is the larger of the two by market cap, and Motorola Solutions Inc pays a 1.08% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Motorola Solutions Inc for 100 Days on average.
| IDXX | MSI | |
|---|---|---|
Market Cap | $40.43B | $74.00B |
Volume | 692,164 | 722,147 |
Sector | Health | Technology |
52-Week High | $766.68 | $491.24 |
52-Week Low | $504.70 | $363.83 |
Typical Hold Time | 46 Days | 100 Days |
Enterprise Value | $41.32B | $82.90B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
MSI trades at $444.18, down 0.96% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $4.41 surpassing the $3.85 estimate. Revenue growth has been steady, reaching $11.68 billion in 2025, and the firm recently announced a $2 billion share repurchase increase and a $139 million public safety contract in Louisiana.
The outlook remains positive with a consensus price target of $525.86, implying 18% upside, supported by a 70.59% buy rating from analysts. Risks include elevated valuation multiples, such as a P/E of 35.23, and significant investing cash outflows for acquisitions, which pressured net cash flow to -$937 million in 2025.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →
